Literature DB >> 20156597

Using decision aids may improve informed consent for research.

Jamie C Brehaut1, Dean A Fergusson, Jonathan Kimmelman, Kaveh G Shojania, Raphael Saginur, Glyn Elwyn.   

Abstract

This commentary argues that the existing approach towards obtaining informed consent for clinical research may be improved by using decision aids. Problems with the current approach include i) an emphasis on documentation to the detriment of good quality decision-making; ii) ad hoc rather than theory-based research studying how to improve informed consent; and iii) a lack of clarity around what is meant by 'comprehension' and how to measure it. Decision aids, which clearly improve patient treatment decisions but are new to decisions surrounding study participation, have strengths in precisely the areas where the informed consent literature is weak. Decision aids facilitate a process of decision-making, combining clear documentation, exercises to facilitate decision-making, and consultation. They are increasingly informed by theory and clear, empirically-derived standards. Furthermore, decision aid research has clearly defined and operationalized three indicators of good quality decision-making in situations where there is no objectively correct answer: demonstrable knowledge of key aspects of the decision, accurate perceptions of the probabilities of various outcomes, and a match between preferred outcomes and the choice made. We identify outstanding issues and propose a research approach that will determine whether the use of decision aids can improve the informed consent process. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20156597     DOI: 10.1016/j.cct.2010.02.002

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  12 in total

1.  Improving informed consent: Stakeholder views.

Authors:  Emily E Anderson; Susan B Newman; Alicia K Matthews
Journal:  AJOB Empir Bioeth       Date:  2017-08-02

Review 2.  Deciding to Enrol in a Cancer Trial: A Systematic Review of Qualitative Studies.

Authors:  Bianca Viljoen; Suzanne K Chambers; Jeff Dunn; Nicholas Ralph; Sonja March
Journal:  J Multidiscip Healthc       Date:  2020-10-27

3.  Thematic analysis of cardiac care patients' explanations for declining contribution to a genomic research-based biobank.

Authors:  Pamela Holtzclaw Williams; Lynne S Nemeth; Jennifer E Sanner; Lorraine Q Frazier
Journal:  Am J Crit Care       Date:  2013-07       Impact factor: 2.228

Review 4.  Patient involvement in clinical research: why, when, and how.

Authors:  José A Sacristán; Alfonso Aguarón; Cristina Avendaño-Solá; Pilar Garrido; Juan Carrión; Alipio Gutiérrez; Robert Kroes; Angeles Flores
Journal:  Patient Prefer Adherence       Date:  2016-04-27       Impact factor: 2.711

5.  Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials.

Authors:  Martin H N Tattersall; Michael Jefford; Andrew Martin; Ian Olver; John F Thompson; Richard F Brown; Phyllis N Butow
Journal:  BMJ Open       Date:  2017-03-01       Impact factor: 2.692

6.  Thought leader perspectives on benefits and harms in precision medicine research.

Authors:  Laura M Beskow; Catherine M Hammack; Kathleen M Brelsford
Journal:  PLoS One       Date:  2018-11-26       Impact factor: 3.240

7.  Details of risk-benefit communication in informed consent documents for phase I/II trials.

Authors:  Hannes Kahrass; Sabine Bossert; Christopher Schürmann; Daniel Strech
Journal:  Clin Trials       Date:  2020-11-24       Impact factor: 2.486

Review 8.  Decision aids for people considering taking part in clinical trials.

Authors:  Katie Gillies; Seonaidh C Cotton; Jamie C Brehaut; Mary C Politi; Zoe Skea
Journal:  Cochrane Database Syst Rev       Date:  2015-11-27

9.  Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trial.

Authors:  I Juraskova; P Butow; C Bonner; M L Bell; A B Smith; M Seccombe; F Boyle; L Reaby; J Cuzick; J F Forbes
Journal:  Br J Cancer       Date:  2014-06-03       Impact factor: 7.640

10.  Developing model biobanking consent language: what matters to prospective participants?

Authors:  Laura M Beskow; Catherine M Hammack-Aviran; Kathleen M Brelsford
Journal:  BMC Med Res Methodol       Date:  2020-05-15       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.